No connection

Search Results

JNJ vs MMSI

JNJ
Johnson & Johnson
NEUTRAL
Price
$237.96
Market Cap
$573.46B
Sector
Healthcare
AI Confidence
85%
MMSI
Merit Medical Systems, Inc.
NEUTRAL
Price
$70.54
Market Cap
$4.21B
Sector
Healthcare
AI Confidence
80%

Valuation

P/E Ratio
JNJ
21.55
MMSI
33.12
Forward P/E
JNJ
18.9
MMSI
16.04
P/B Ratio
JNJ
7.03
MMSI
2.65
P/S Ratio
JNJ
6.09
MMSI
2.77
EV/EBITDA
JNJ
17.81
MMSI
14.4

Profitability

Gross Margin
JNJ
68.08%
MMSI
48.7%
Operating Margin
JNJ
23.97%
MMSI
15.78%
Profit Margin
JNJ
28.46%
MMSI
8.48%
ROE
JNJ
35.03%
MMSI
8.67%
ROA
JNJ
8.68%
MMSI
4.75%

Growth

Revenue Growth
JNJ
9.1%
MMSI
10.9%
Earnings Growth
JNJ
48.6%
MMSI
38.8%

Financial Health

Debt/Equity
JNJ
0.6
MMSI
0.52
Current Ratio
JNJ
1.03
MMSI
4.34
Quick Ratio
JNJ
0.69
MMSI
2.79

Dividends

Dividend Yield
JNJ
2.19%
MMSI
--
Payout Ratio
JNJ
46.6%
MMSI
0.0%

AI Verdict

JNJ NEUTRAL

JNJ presents a dichotomy between strong profitability and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 3/9. While the company maintains an impressive ROE of 35.03% and a consistent history of earnings beats, the current price of $237.96 trades at a significant premium to its Graham Number of $91.72. Growth remains robust on a YoY basis, but bearish insider sentiment and a very weak technical trend (10/100) suggest immediate headwinds. The stock is fundamentally sound in terms of earnings power but shows signs of operational inefficiency or declining quality in its deterministic health metrics.

Strengths
Exceptional Return on Equity (ROE) of 35.03%
Strong profit margins (28.46%) and gross margins (68.08%)
Consistent earnings beat track record over 25 quarters
Risks
Weak Piotroski F-Score (3/9) indicating declining fundamental health
Bearish insider activity with $58.35M in net sales and zero buys
Low liquidity indicated by a Quick Ratio of 0.69
MMSI NEUTRAL

MMSI presents a dichotomy between strong fundamental growth and poor market sentiment. While the Piotroski F-Score of 4/9 indicates stable but not strong financial health, the company boasts an exceptional track record of earnings beats over 25 quarters and strong YoY earnings growth of 38.8%. However, the stock is currently trading at $70.54, which is a premium to its Intrinsic Value ($62.83) and significantly above its Graham Number ($35.75). Bearish insider activity and a 0/100 technical trend offset the bullish analyst target of $101.18.

Strengths
Exceptional earnings track record with consistent beats over 25 quarters
Strong liquidity position with a Current Ratio of 4.34
Significant earnings growth (38.8% YoY) and positive Q/Q momentum
Risks
Trading at a premium to both Graham Number and Intrinsic Value
Strongly bearish insider sentiment with $5.64M in recent sales
Severe negative technical trend (0/100) and 1Y price decline of 24.4%

Compare Another Pair

JNJ vs MMSI: Head-to-Head Comparison

This page compares Johnson & Johnson (JNJ) and Merit Medical Systems, Inc. (MMSI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile